Open
SectorHealthcare
7.5 3.45
24h
Min
7.04
Max
7.68
Income | -354K -23M |
---|---|
Sales | -2M 15M |
EPS | -1.06 |
Profit margin | -151.708 |
Employees | 131 |
EBITDA | -1.2M -21M |
Recommendations | Buy |
---|---|
12 Months Forecast | +128.19% upside |
Next Earnings | 1 sie 2025 |
---|
Market Cap | 34M 152M |
---|---|
Previous open | 4.05 |
Previous close | 7.5 |
By Acuity
50%
50%
154 / 380 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 17 USD 128.19%
High 24 USD
Low 7 USD
Based on 3 Wall Street analysts offering 12 month price targets forENANTA PHARMACEUTICALS INC - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$